Table 5.
Details of SARS-CoV2–positive neonates (n = 5)
| Neonate 1 | Neonate 2 | Neonate 3 | Neonate 4 | Neonate 5 | |
|---|---|---|---|---|---|
| Sex | Female | Female | Female | Male | Male |
| Gestational age, wk | 375 | 32 | 356 | 40 | 38 |
| Birthweight, g | 2680 | 1160 | 1800 | 3370 | 2750 |
| Mode of delivery | NVD | LSCS | NVD | NVD | NVD |
| Day of maternal positivity | At delivery | Positive twice (13 and 4 d before delivery), negative on day of LSCS | Day 2 postpartum |
Before delivery | Day 2 postpartum |
| Neonate age at testing | Within 24 h of birth | Day 14 of life | Day 4 of life | Day 1 of life | Day 4 of life |
| Intrauterine growth status | AGA | SGA | SGA | AGA | AGA |
| Onset of symptoms | Asymptomatic | Asymptomatic | Asymptomatic | Asymptomatic | Since birth |
| Isolation status | Yes (mother sick) | Yes (baby admitted to NICU) | No | No | Yes (baby had tachypnea) |
| Breastfeeding | No (mother in ICU) | Yes (EBM) | Yes | Yes | EBM |
| Management | Supportive | Supportive | Supportive | Supportive | CPAP |
| Duration of hospital stay, d | 8 | 15 | 10 | 8 | 10 |
| Timing of maternal symptom onset | COVID-19–positive before delivery; died on day 3 | Fever 7 d before delivery | Fever on day 2, mild symptoms | COVID-19–positive at delivery | Fever on day 2 |
AGA: appropriate for gestational age; CPAP: continuous positive airway pressure therapy; EBM: expressed breast milk; ICU: intensive care unit; LSCS: lower segment cesarean section; NICU: neonatal intensive care unit; NVD: normal vaginal delivery; SGA: small for gestational age.